We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Expert Opinion / Cases · November 30, 2022

Concurrent Recurrent Metastatic Breast Cancer With Lung Sarcoidosis

Written by
Jing Xi MD, MPH

 

Discuss This item Follow

No comments yet, be the first to start the discussion!

  • Susan Sadighi

    Nov 30, 2022

    Based on imaging and tumor marker reports, I believed letrozole worked very well in this case. We can preserve CDK 4/6 Inh. if the metastases show progression. Since the patient has no symptoms and we can not exclude lung metastasis, I do not agree with neck radiation too.  

  • Amiy Arnav

    Jan 07, 2023

    In view of the prolonged disease-free survival and good response to Letrozole, I will suggest continuing the current management and reserve CDK4/6 Inhb for progression. Radiation may not be of much use to us.

  • Jan 30, 2023

    Pending Moderator approval.
    Delete

Further Reading